Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age (French, HTML)

View metadata and access the original French HTML file: Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age.

Format

HTML

Access

file-only

Publisher-reported update

2021-11-05

The Pfizer-BioNTech and Moderna COVID-19 vaccines are mRNA vaccines that were initially authorized by Health Canada for use in individuals 16 and 18 years of age and older, respectively, in December 2020. On May 5, 2021, Health Canada expanded the Interim Order authorization for the Pfizer-BioNTech COVID-19 vaccine to also include adolescents 12 to 15 years of age based on clinical trial results in this age group.

Access original file